Concepedia

Maria Jeleva

MJ

Statistics

Publications

2

Citations

62

H-Index

2

Active since

2019

Affiliations

Impel Neuropharma (United States)(Current)

Maria Jeleva is an author at Impel Neuropharma (United States).

Publications per year

2019–2021

2

Publications

2

STOP 101: A Phase 1, Randomized, Open‐Label, Comparative Bioavailability Study of INP104, Dihydroergotamine Mesylate (DHE) Administered Intranasally by a I123 Precision Olfactory Delivery (POD <sup>®</sup> ) Device, in Healthy Adult Subjects

Stephen B. Shrewsbury, Maria Jeleva, Kelsey Satterly et al. · Headache The Journal of Head and Face Pain · 2019 · 34 citations · Full text

STOP 301: A Phase 3, open‐label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD <sup>®</sup> ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients

Timothy R. Smith, Paul Winner, Sheena K. Aurora et al. · Headache The Journal of Head and Face Pain · 2021 · 28 citations · Full text

1–2 of 2